missing translation for 'onlineSavingsMsg'
Learn More
Learn More
AGER (M02), Mouse anti-Human, Clone: 1C1, Abnova™
Mouse monoclonal antibody raised against a full-length recombinant AGER.
Marque: Abnova H00000177-M02C.200uL
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
This gene encodes a member of the immunoglobulin superfamily of cell surface molecules. It is a receptor for various molecules, including the amyloidogenic form of serum amyloid A, amyloid-beta protein, members of the S100/calgranulin superfamily and advanced glycation end products. The gene lies within the major histocompatibility complex (MHC) class III region on chromosome 6. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq
Sequence: AQNITARIGEPLVLKCKGAPKKPPQRLEWNLNTGRTEAWKVLSPQGGGPWDSVARVLPNGSLFLPAVGIQDEGIFRCQAMNRNGKETKSNYRVRVYQIPGKPEIVDSASELTAGVPNKVGTCVSEGSYPAGTLSWHLDGKPLVPNEKGVSVKEQTRRHPETGLFTLQSELMVTPARGGDPRPTFSCSFSPGLPRHRALRTAPIQPRVWEPVPLEEVQLVVEPEGGAVAPGGTVTLTCEVPAQPSPQIHWMKDGVPLPLPPSPVLILPEIGPQDQGTYSCVATHSSHGPQESRAVSISIIEPGEEGPTAGSVGGSGLGTLALALGILGGLGTAALLIGVILWQRRQRRGEERKAPENQEEEEERAELNQSEEPEAGESSTGGPSpécification
| AGER | |
| Monoclonal | |
| Unconjugated | |
| tissue culture supernatant with no preservative | |
| BC020669 | |
| AGER | |
| AGER (AAH20669.1, 23 a.a. ∼ 404 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. | |
| RUO | |
| 177 | |
| Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. | |
| Ascites |
| ELISA, Western Blot | |
| 1C1 | |
| Mouse monoclonal antibody raised against a full-length recombinant AGER. | |
| AGER | |
| MGC22357/RAGE | |
| Mouse | |
| 200 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG2a κ |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
AGER (M02), Mouse anti-Human, Clone: 1C1, Abnova™ > 200μL; Unlabeled
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu
